EUVIMEDEUVIMED entdecken
Crossref

Thrombin‐Responsive Multiarmed Nanovesicles for Targeted Delivery of Tissue Plasminogen Activator and MRI‐Monitored Thrombolysis

Yu Huang iD, Jinlong Zhang, Xuehao Yu, Qiang Zhang iD, Xinhua Liu, Yidan Zhang, Cailing Li, Zeyun Xu, Enguang Chen, Tingting Yao, Mingkang Wang, Jiahua Wang iD und 3 weitere

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.71632 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Yu Huang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Tissue Plasminogen Activator, Thrombin, Magnetic Resonance Imaging, Thrombolytic Therapy. Die Arbeit nennt 73 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Shanghai Sixth People's Hospital, Shanghai Oriental Talent Program-Team Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An ordered therapeutic sequence in which target engagement precedes site‐restricted payload delivery provides a conceptual framework for precision thrombolysis. Guided by this process‐level logic, we engineered a multiarmed nanovesicle, termed tPA@CTG, that integrates CREKA‐mediated thrombus targeting, thrombin‐responsive activation, localized tissue plasminogen activator release, and MRI monitoring. tPA@CTG achieves efficient thrombus targeting under both static and flow conditions, along with thrombin‐triggered structural activation and localized tPA release. In a rat carotid artery thrombosis model, tPA@CTG restores near‐complete recanalization with a thrombolytic efficiency of 99.5 ± 0.6% and blood flow recovery of 95.1 ± 2.5%, substantially outperforming free tPA. Remarkably, even at half the dose, tPA@CTG remains more effective than full‐dose free tPA, highlighting the therapeutic benefit of combining thrombus targeting with thrombin‐responsive local release. Transcriptomic analysis reveals modulation of complement and coagulation pathways, indicating active remodeling of the thrombotic microenvironment beyond simple clot dissolution. Biosafety assessments confirm excellent biocompatibility and substantially reduced bleeding risk compared to free tPA. Together, tPA@CTG provides an integrated platform for targeted, thrombin‐responsive, and MRI‐monitored thrombolysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tissue Plasminogen ActivatorThrombinMagnetic Resonance ImagingThrombolytic TherapyNanoparticlesDrug Delivery SystemsAnimalsRatsMaleHumansRats, Sprague-DawleyThrombosisFibrinolytic Agents

Stichwörter der Autor:innen

magnetic resonance imagingmultiarmed nanovesiclestheranosticsthrombin‐responsive releasethrombolysis

Substanzen

Tissue Plasminogen ActivatorThrombinFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Radiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • School of Information and Intelligent Science, Donghua University, Shanghai, P. R. China.
  • School of Energy and Materials, Shanghai Polytechnic University, Shanghai, P. R. China.
  • Wuhan United Imaging Life Science Instruments Ltd., Wuhan, Hubei, P. R. China.

ORCID-Profile: Yu Huang, Qiang Zhang, Jiahua Wang, Yuehua Li

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Shanghai Sixth People's Hospital
  • Shanghai Oriental Talent Program-Team Project
  • Innovative Research Team of High-Level Local Universities in Shanghai

Zitieren

APA

Huang, Y., Zhang, J., Yu, X., Zhang, Q., Liu, X., Zhang, Y., Li, C., Xu, Z., Chen, E., Yao, T., Wang, M., Wang, J., Guo, Y., Zhu, Y., & Li, Y. (2026). Thrombin‐Responsive Multiarmed Nanovesicles for Targeted Delivery of Tissue Plasminogen Activator and MRI‐Monitored Thrombolysis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71632

Vancouver

Huang Y, Zhang J, Yu X, Zhang Q, Liu X, Zhang Y, et al. Thrombin‐Responsive Multiarmed Nanovesicles for Targeted Delivery of Tissue Plasminogen Activator and MRI‐Monitored Thrombolysis. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71632

BibTeX
@article{Huang2026,
  author = {Huang, Yu and Zhang, Jinlong and Yu, Xuehao and Zhang, Qiang and Liu, Xinhua and Zhang, Yidan and Li, Cailing and Xu, Zeyun and Chen, Enguang and Yao, Tingting and Wang, Mingkang and Wang, Jiahua and Guo, Yuanyuan and Zhu, Yueqi and Li, Yuehua},
  title = {Thrombin‐Responsive Multiarmed Nanovesicles for Targeted Delivery of Tissue Plasminogen Activator and MRI‐Monitored Thrombolysis},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71632}
}
Kostenlos starten →